Immunohistochemistry (IHC) confirmed the diagnosis of a solitary fibrous tumor with positive B-cell lymphoma 2 (BCL2), STAT6, CD34, and CD99 and negative S100 and smooth muscle actin (SMA). The gene discussed is CD99; the disease is solitary fibrous tumor.